IFRS - Issues and solutions for the pharmaceuticals and life sciences industry - 2019 edition

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.

Issues and solutions for the pharmaceuticals and life sciences industry

This report addresses particular accounting issues the pharmaceuticals and life sciences sector faces when using the International Financial Reporting Standards (IFRS). The aim is to highlight the industry-specific factors which need to be considered, and to provide an opinion on the most pertinent accounting solutions for common commercial transactions under IFRS. Each solution is based on a specified set of circumstances. They cover general situations and provide a framework for determining the appropriate accounting answer but individual fact patterns may give rise to a different answer. Examples cover various practices in the following areas:

  • Research and development and Intangibles
  • Manufacturing and supply chain
  • Funding for R&D
  • Business combinations and asset acquisitions
  • Revenue recognition (IFRS 15)
  • Presentation and disclosure

 

 

Steel and aluminum

Contact us

Peter Kartscher

Global Pharma/LS Assurance Leader, PwC Switzerland

Tel: +41 79 5429018

Ruth Preedy

Director, IFRS specialist

Tel: +44 20 721 32123

Follow us